NTSR2 Antibody (LS-B1768)

貨號 Cat. No.
LS-B1768
規格 Size
50 µg
品牌 Brand
LSBio

Description





























































































Antibody Catalog ID: LS-B1768
Antibody Validation: This antibody replaces catalog number LS-C47272. It has been validated for use in the following assays: IHC.
Antibody Target: Neurotensin Receptor Type 2 (NTR2) (NTSR2)
Synonyms: NTSR2, levocabastine-sensitive neurotensin receptor, levocabastine-sensitive receptor , neurotensin NT2 receptor, neurotensin receptor 2, neurotensin receptor type 2, NT2 receptor, ntr2, ntsr2
Family: GPCR
Subfamily: Neurotensin
Host: NTSR2 antibody was produced in Rabbit
Antigen Species: NTSR2 antibody was raised against Human
Clonality: Polyclonal
Isotype: IgG
Antigen Type: Synthetic peptide - KLH conjugated
Immunogen: NTSR2 antibody was raised against synthetic peptide
Antibody Specificity: A portion of amino acids 150-200 of human Neurotensin receptor 2
Antigen Modification: aa150-200
Predicted Species Reactivity: Bovine, Dog, Mouse, Rat
Purification: Immunoaffinity Chromatography
Presentation: PBS, 0.2% gelatin, 0.05% sodium azide.
Recommended Storage: Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles.
Antibody Usage Summary: Immunohistochemistry: LS-B1768 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D1, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B1768 was determined to be 10 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (10 µg/ml), Western blot (WB) (0.2 - 2 µg/ml) (Optimal dilution to be determined by the researcher)
Size: 50 µg
Concentration: 0.5 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢